Latest News
- Min. Nadda Unveils ?13,000-Crore Bio-Pharma SHAKTI and Chemical Parks Push to Expand India’s Global Chemicals and Biologics Footprint
- Aurobindo Pharma Subsidiary Launches Generic Cancer Drug in US, Expands Oncology Portfolio in Global Generics Market
- KIMS Hospitals Introduces Adaptive Deep Brain Stimulation in India for Advanced Parkinson’s Treatment
ADIA to Invest $200 Million in MedTech Firm Meril, Valuing the Company at $6.6 Billion
This strategic investment marks ADIA’s growing interest in India’s burgeoning medical technology and manufacturing sector. Once completed, the deal will bring Meril under the financial patronage of two global investment powerhouses—ADIA and Warburg Pincus.
- By Newsdesk
- Ahmedabad
- Jul 21, 2025
The Abu Dhabi Investment Authority (ADIA) has announced a $200 million (approximately ₹1,723 crore) investment in Gujarat-based medical devices manufacturer Meril, acquiring nearly a 3% stake in the company. The deal, which values Meril at $6.6 billion (around ₹56,859 crore), is currently pending regulatory clearance from the Competition Commission of India (CCI).
This strategic investment marks ADIA’s growing interest in India’s burgeoning medical technology and manufacturing sector. Once completed, the deal will bring Meril under the financial patronage of two global investment powerhouses—ADIA and Warburg Pincus.
Founded by the Bilakhia Group, Meril operates a sprawling 100-acre MedTech campus in Vapi, Gujarat. The state-of-the-art facility is vertically integrated and runs entirely on renewable energy, reflecting the company’s commitment to sustainability alongside innovation.
Meril designs and manufactures a comprehensive portfolio of advanced medical technologies, including cardiovascular devices, structural heart products, robotic surgery systems, orthopaedic implants, diagnostic kits, and endosurgical tools. To date, it has invested ₹1,400 crore in its manufacturing infrastructure.
In December 2024, Meril expanded its footprint with the inauguration of a new medical devices plant in Vapi, further strengthening its production capabilities.
With a global workforce exceeding 13,000, Meril exports to over 150 countries and operates more than 35 international subsidiaries. It also runs 12 training academies worldwide, equipping over 10,000 healthcare professionals annually with hands-on experience in cutting-edge medical technologies.
The ADIA investment reinforces the rising global confidence in India’s medtech sector and signals Meril’s growing influence as a world-class healthcare technology provider.